Oral Terbinafine and Itraconazole Combined with Intralesional Amphotericin B Therapy Against Large Chromoblastomycosis Lesions

Mycopathologia. 2022 Dec;187(5-6):619-621. doi: 10.1007/s11046-022-00675-0. Epub 2022 Oct 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B*
  • Antifungal Agents / therapeutic use
  • Chromoblastomycosis* / diagnosis
  • Chromoblastomycosis* / drug therapy
  • Humans
  • Itraconazole
  • Microbial Sensitivity Tests
  • Terbinafine

Substances

  • Terbinafine
  • Amphotericin B
  • Itraconazole
  • Antifungal Agents